Hunova, the first robotic gym for the rehabilitation and functional motor sense evaluation of lower limbs and trunk, has been officially launched in Genoa, Italy. The first 30 robots will be available from June in Europe and the USA. The technology was developed and patented at the IIT laboratories and has been launched on the market thanks to a 10 million euro investment from entrepreneur Sergio Dompè.
Hunova is a programmable robotic medical device that allows professionals in the geriatrics, neurology and sport rehabilitation field to cure and predict many neurological and orthopedic conditions. There are two main competitive advantages of this technology: Hunova is able to collect a significant amount of data on biomechanics, constantly monitoring the patient’s progress. Secondly, it provides direct support to the patient through a guiding robotic system, offering a wide range of rehabilitation protocols in the form of video games. It consists of two electromechanical platforms equipped with sensors, characterized by two degrees of freedom (feet and seat level). The device integrates the force sensors to adjust the interaction with the patient and a wireless sensor, which is placed on the patient’s trunk, allowing the physiotherapist to check the movement of the torso.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8108951-iit-movendo-launch-robot-hunova/
http://www.glosunspa.com ~ Houston Tanning Salon ~ Phone (713) 662-9200 Glo Sun Spa is the most luxurious spot in Houston for indoor tanning and skin care. Glo is actually a working showroom that features all the newest technology from the top manufacturers worldwide. Equipment choices include VersaSpa, Lumiere Light Therapy, Ergoline, KBL America, Tan America, Sportareddo, Dr. Mueller, Hydration Station, and Sun Italia. When you become a member at Glo Sun Spa, you can indulge in all the finest equipment available worldwide! Enjoy! Glo Sun Spa, 3273 Southwest Freeway, Houston, TX 77027, (713) 662-9200 http://www.glosunspa.com
Superstar model, producer, television host and designer Heidi Klum unveiled her secret to strong, beautiful hair last year with the launch of CLEAR SCALP & HAIR BEAUTY THERAPY™, and is now asking women everywhere to join her in the 7 Day Scalp & Hair Challenge for stronger, more beautiful hair in 7 days.
From frequent red carpet appearances to countless hours on set at photo shoots, Klum goes through rigorous daily styling that really takes a toll on her scalp and hair. To nourish her scalp for stronger, more beautiful hair, and to gear up for her next big event, Klum turned to the 7 Day Scalp & Hair Challenge. As part of the challenge, Klum is using CLEAR SCALP & HAIR BEAUTY THERAPY™ shampoo and conditioner daily before styling.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60396-clear-scalp-and-hair-beauty-therapy-heidi-klum-seven-day-challenge
As the American Massage Therapy Association® (AMTA®) marks its 15th annual National Massage Therapy Awareness Week October 23 – October 29, 2011, more consumers are using massage therapy for pain relief and other health issues. In fact, according to a recent consumer survey commissioned by AMTA, consumers are progressively integrating massage therapy into their regular health maintenance routines.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52739-american-massage-therapy-association-amta-pain-relief-health-benefits
Visit www.thespiritconnect.com for more New Age Videos, Articles and Discussion on Meditation, Yoga, Astrology, Accupuncture, Qi-Gong.
Sound is a powerful, primitive force. For Centuries, healers have intuitively used the therepeautic powers of sound. In the native traditions of ancient cultures, examples of sound and vibration--as elemental in creation and to wholeness--abound. Many tools have been used since the beginning of time to create music, and to aid healing: planetary gongs and Tibetan bowls, didgeridoos, rattles and drums. Today, a growing number of modern practitioners are rediscovering sound as a tool for healing and realignment. More modern sound therapy tools are--tuning forks, chimes, resonator plates, sound discs, and sound tables. All play an important role in healing. Sound is that which is produced when some object is vibrating in a random or periodic repeated motion.
Approximately 80 million American men and women experience some form of hair loss. Premature balding or thinning hair can often result in a decrease of self esteem. Freedom Laser Therapy of Los Angeles is dedicated to change all that by bringing their iRestore Hair Rejuvenation System to the mass market.
This proven, safe Laser Hair Restoration Technology, otherwise known as phototherapy, is a scientific process providing stimulation to cells in your hair. The 25-year old advanced low-level laser treatment stimulates the scalp, allowing miniaturized and dormant hair follicles to rejuvenate.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54394-freedom-laser-therapy-laser-hair-treatment-regrowth-restoration
New findings from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form.
The finding also led investigators to a new treatment target and possible therapy for the rare childhood tumor of the retina, the light-sensing tissue at the back of the eye. The study appears in the January 11 advance online edition of the scientific journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46767-st-jude-genome-project-treatment-childhood-eye-tumor-retinoblastoma
Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children’s Research Hospital and at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results of this study appear today in the journal Science Translational Medicine.
The study involved five males with X-linked severe combined immunodeficiency disease (SCID-X1), also known as “Bubble Boy” disease, who were all treated at NIAID. This inherited disorder involves a mutation in the IL2RG gene that affects males and occurs in 1 of every 50,000 to 100,000 live births, leaving them with little to no immune protection.
To view the multimedia release go to:
http://www.multivu.com/players/English/7808651-st-jude-gene-therapy-results/
Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children’s Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K.
The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder. Results of the Phase I study appear in the December 10 online edition of the New England Journal of Medicine. The research is also scheduled to be presented December 11 at the 53rd annual meeting of the American Society of Hematology in San Diego.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46766-st-jude-children-s-research-hospital-gene-therapy-bleeding-disorder
Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
